BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 22191803)

  • 1. Mephedrone, an abused psychoactive component of 'bath salts' and methamphetamine congener, does not cause neurotoxicity to dopamine nerve endings of the striatum.
    Angoa-Pérez M; Kane MJ; Francescutti DM; Sykes KE; Shah MM; Mohammed AM; Thomas DM; Kuhn DM
    J Neurochem; 2012 Mar; 120(6):1097-107. PubMed ID: 22191803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3,4-Methylenedioxypyrovalerone prevents while methylone enhances methamphetamine-induced damage to dopamine nerve endings: β-ketoamphetamine modulation of neurotoxicity by the dopamine transporter.
    Anneken JH; Angoa-Pérez M; Kuhn DM
    J Neurochem; 2015 Apr; 133(2):211-22. PubMed ID: 25626880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mephedrone does not damage dopamine nerve endings of the striatum, but enhances the neurotoxicity of methamphetamine, amphetamine, and MDMA.
    Angoa-Pérez M; Kane MJ; Briggs DI; Francescutti DM; Sykes CE; Shah MM; Thomas DM; Kuhn DM
    J Neurochem; 2013 Apr; 125(1):102-10. PubMed ID: 23205838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of combined treatment with mephedrone and methamphetamine or 3,4-methylenedioxymethamphetamine on serotonin nerve endings of the hippocampus.
    Angoa-Pérez M; Kane MJ; Herrera-Mundo N; Francescutti DM; Kuhn DM
    Life Sci; 2014 Feb; 97(1):31-6. PubMed ID: 23892197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing the role of dopamine in the differential neurotoxicity patterns of methamphetamine, mephedrone, methcathinone and 4-methylmethamphetamine.
    Anneken JH; Angoa-Perez M; Sati GC; Crich D; Kuhn DM
    Neuropharmacology; 2018 May; 134(Pt A):46-56. PubMed ID: 28851615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 4-Methylmethcathinone (mephedrone): neuropharmacological effects of a designer stimulant of abuse.
    Hadlock GC; Webb KM; McFadden LM; Chu PW; Ellis JD; Allen SC; Andrenyak DM; Vieira-Brock PL; German CL; Conrad KM; Hoonakker AJ; Gibb JW; Wilkins DG; Hanson GR; Fleckenstein AE
    J Pharmacol Exp Ther; 2011 Nov; 339(2):530-6. PubMed ID: 21810934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissociation between hypothermia and neurotoxicity caused by mephedrone and methcathinone in TPH2 knockout mice.
    Anneken JH; Angoa-Perez M; Sati GC; Crich D; Kuhn DM
    Psychopharmacology (Berl); 2019 Mar; 236(3):1097-1106. PubMed ID: 30074064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissecting the Influence of Two Structural Substituents on the Differential Neurotoxic Effects of Acute Methamphetamine and Mephedrone Treatment on Dopamine Nerve Endings with the Use of 4-Methylmethamphetamine and Methcathinone.
    Anneken JH; Angoa-Pérez M; Sati GC; Crich D; Kuhn DM
    J Pharmacol Exp Ther; 2017 Mar; 360(3):417-423. PubMed ID: 28039330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose and time-dependent selective neurotoxicity induced by mephedrone in mice.
    Martínez-Clemente J; López-Arnau R; Abad S; Pubill D; Escubedo E; Camarasa J
    PLoS One; 2014; 9(6):e99002. PubMed ID: 24892744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of binge-dosed methamphetamine-induced neurotoxicity and neuroinflammation.
    McConnell SE; O'Banion MK; Cory-Slechta DA; Olschowka JA; Opanashuk LA
    Neurotoxicology; 2015 Sep; 50():131-41. PubMed ID: 26283213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methamphetamine self-administration causes persistent striatal dopaminergic alterations and mitigates the deficits caused by a subsequent methamphetamine exposure.
    McFadden LM; Hadlock GC; Allen SC; Vieira-Brock PL; Stout KA; Ellis JD; Hoonakker AJ; Andrenyak DM; Nielsen SM; Wilkins DG; Hanson GR; Fleckenstein AE
    J Pharmacol Exp Ther; 2012 Feb; 340(2):295-303. PubMed ID: 22034657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term consequences of methamphetamine exposure in young adults are exacerbated in glial cell line-derived neurotrophic factor heterozygous mice.
    Boger HA; Middaugh LD; Patrick KS; Ramamoorthy S; Denehy ED; Zhu H; Pacchioni AM; Granholm AC; McGinty JF
    J Neurosci; 2007 Aug; 27(33):8816-25. PubMed ID: 17699663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Polytox" synthetic cathinone abuse: A potential role for organic cation transporter 3 in combined cathinone-induced efflux.
    Mayer FP; Schmid D; Holy M; Daws LC; Sitte HH
    Neurochem Int; 2019 Feb; 123():7-12. PubMed ID: 30248432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epothilone D prevents binge methamphetamine-mediated loss of striatal dopaminergic markers.
    Killinger BA; Moszczynska A
    J Neurochem; 2016 Feb; 136(3):510-25. PubMed ID: 26465779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methamphetamine neurotoxicity in dopamine nerve endings of the striatum is associated with microglial activation.
    Thomas DM; Walker PD; Benjamins JA; Geddes TJ; Kuhn DM
    J Pharmacol Exp Ther; 2004 Oct; 311(1):1-7. PubMed ID: 15163680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mephedrone and methylenedioxypyrovalerone (MDPV), major constituents of "bath salts," produce opposite effects at the human dopamine transporter.
    Cameron K; Kolanos R; Vekariya R; De Felice L; Glennon RA
    Psychopharmacology (Berl); 2013 Jun; 227(3):493-9. PubMed ID: 23371489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of endogenous serotonin in methamphetamine-induced neurotoxicity to dopamine nerve endings of the striatum.
    Thomas DM; Angoa Pérez M; Francescutti-Verbeem DM; Shah MM; Kuhn DM
    J Neurochem; 2010 Nov; 115(3):595-605. PubMed ID: 20722968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine D2-receptor knockout mice are protected against dopaminergic neurotoxicity induced by methamphetamine or MDMA.
    Granado N; Ares-Santos S; Oliva I; O'Shea E; Martin ED; Colado MI; Moratalla R
    Neurobiol Dis; 2011 Jun; 42(3):391-403. PubMed ID: 21303698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurotoxicology of Synthetic Cathinone Analogs.
    Angoa-Pérez M; Anneken JH; Kuhn DM
    Curr Top Behav Neurosci; 2017; 32():209-230. PubMed ID: 27753008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurotoxicity Induced by Mephedrone: An up-to-date Review.
    Pantano F; Tittarelli R; Mannocchi G; Pacifici R; di Luca A; Busardò FP; Marinelli E
    Curr Neuropharmacol; 2017; 15(5):738-749. PubMed ID: 27908258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.